Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amber J Hackstadt

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|October 4, 2016
Estimating the health benefit of reducing indoor air pollution in a randomized environmental interventionRoger D Peng, Arlene M Butz, Amber J Hackstadt, et al.
Statistics in Medicine|August 29, 2014
Inference for environmental intervention studies using principal stratificationAmber J Hackstadt, Elizabeth C Matsui, D'Ann L Williams, et al.
Annals of Internal Medicine|May 8, 2023
Primary Occurrence of Cardiovascular Events After Adding Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With DiabetesTadarro L Richardson, Alese E Halvorson, Amber J Hackstadt, et al.
Diabetes, Obesity & Metabolism|August 3, 2019
Evaluation of weight change and hypoglycaemia as mediators in the association between insulin use and deathJea Young Min, Amber J Hackstadt, Marie R Griffin, et al.
Journal of the American Heart Association|April 6, 2021
Hospitalization for Heart Failure Among Patients With Diabetes Mellitus and Reduced Kidney Function Treated With Metformin Versus Sulfonylureas: A Retrospective Cohort StudyTadarro L Richardson, Amber J Hackstadt, Adriana M Hung, et al.
Diabetes Care|April 25, 2020
Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or SulfonylureasPatricia Y Chu, Amber J Hackstadt, Jonathan Chipman, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|December 27, 2023
The Teledermatology Experience: Cost Savings and Image Quality ControlMatthew M Wallace, Amber J Hackstadt, Zijun Zhao, et al.
Cancer Causes & Control : CCC|July 20, 2018
Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancerHarvey J Murff, Christianne L Roumie, Robert A Greevy, et al.
JAMA|September 20, 2019
Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney FunctionChristianne L Roumie, Jonathan Chipman, Jea Young Min, et al.
JMIR Research Protocols|June 28, 2024
Effects of a Patient Portal Intervention to Address Diabetes Care Gaps: Protocol for a Pragmatic Randomized Controlled TrialAmber J Hackstadt, Tom A Elasy, Sapna Gangaputra, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of the Royal Statistical Society. Series A, (Statistics in Society)|October 4, 2016
Estimating the health benefit of reducing indoor air pollution in a randomized environmental interventionRoger D Peng, Arlene M Butz, Amber J Hackstadt, et al.
Statistics in Medicine|August 29, 2014
Inference for environmental intervention studies using principal stratificationAmber J Hackstadt, Elizabeth C Matsui, D'Ann L Williams, et al.
Annals of Internal Medicine|May 8, 2023
Primary Occurrence of Cardiovascular Events After Adding Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With DiabetesTadarro L Richardson, Alese E Halvorson, Amber J Hackstadt, et al.
Diabetes, Obesity & Metabolism|August 3, 2019
Evaluation of weight change and hypoglycaemia as mediators in the association between insulin use and deathJea Young Min, Amber J Hackstadt, Marie R Griffin, et al.
Journal of the American Heart Association|April 6, 2021
Hospitalization for Heart Failure Among Patients With Diabetes Mellitus and Reduced Kidney Function Treated With Metformin Versus Sulfonylureas: A Retrospective Cohort StudyTadarro L Richardson, Amber J Hackstadt, Adriana M Hung, et al.
Diabetes Care|April 25, 2020
Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or SulfonylureasPatricia Y Chu, Amber J Hackstadt, Jonathan Chipman, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|December 27, 2023
The Teledermatology Experience: Cost Savings and Image Quality ControlMatthew M Wallace, Amber J Hackstadt, Zijun Zhao, et al.
Cancer Causes & Control : CCC|July 20, 2018
Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancerHarvey J Murff, Christianne L Roumie, Robert A Greevy, et al.
JAMA|September 20, 2019
Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney FunctionChristianne L Roumie, Jonathan Chipman, Jea Young Min, et al.
JMIR Research Protocols|June 28, 2024
Effects of a Patient Portal Intervention to Address Diabetes Care Gaps: Protocol for a Pragmatic Randomized Controlled TrialAmber J Hackstadt, Tom A Elasy, Sapna Gangaputra, et al.
Pageof 3